U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856407) titled 'Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies' on Sept. 28.
Brief Summary: Severe asthma is a debilitating disease that affects every aspect of patients' lives: daily life, work, social life, family life, and marital life. The advent of biologic therapies has transformed these patients' quality of life by improving asthma control, access to care, and overall quality of life. But how do patients actually experience this transformation in their lives? What has actually changed for them, based on their own perceptions? Investigator hypothesize that a hypothetical-deductive qualitative study with a methodol...